Cargando…
New and emerging agents in the management of lipodystrophy in HIV-infected patients
Lipodystrophy remains a major long-term complication in human immunodeficiency virus-infected patients under antiretroviral (ARV) therapy. Patients may present with lipoatrophy or lipohypertrophy or both. The choice of treatments to improve fat redistribution depends on the form of lipodystrophy and...
Autor principal: | Bonnet, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218685/ https://www.ncbi.nlm.nih.gov/pubmed/22096395 http://dx.doi.org/10.2147/HIV.S13429 |
Ejemplares similares
-
Lipodystrophy in HIV patients: its challenges and management approaches
por: Singhania, Rohit, et al.
Publicado: (2011) -
Growth hormone and tesamorelin in the management of HIV-associated lipodystrophy
por: Bedimo, Roger
Publicado: (2011) -
The Effects of Thiazolidinediones on Metabolic Complications and Lipodystrophy in HIV-Infected Patients
por: Sutinen, Jussi
Publicado: (2009) -
Biochemical Manifestation of HIV Lipodystrophy Syndrome
por: Ihenetu, Kenneth, et al.
Publicado: (2012) -
HIV/AIDS and lipodystrophy: Implications for clinical management in resource-limited settings
por: Finkelstein, Julia L, et al.
Publicado: (2015)